Khoshbaten M - Search Results

1

The efficacy of topical sodium pentaborate formulation on hemorrhoid disease: A randomized, double-blind, placebo-controlled trial.

Şahin F, Farshbaf-Khalili A, Alihosseini S, Sarbakhsh P, Pirouzpanah MS, Ayşan E, Doğan A, Gharekhani A, Khoshbaten M, Pirouzpanah MB. Şahin F, et al. Among authors: khoshbaten m. Heliyon. 2024 Feb 29;10(5):e27215. doi: 10.1016/j.heliyon.2024.e27215. eCollection 2024 Mar 15. Heliyon. 2024. PMID: 38463771 Free PMC article.

2

Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.

Khoshbaten M, Beheshtirouy S, Shayanrad S, Gharekhani A, Rezaee H. Khoshbaten M, et al. Drug Res (Stuttg). 2023 Apr;73(4):232-237. doi: 10.1055/a-1997-0401. Epub 2023 Feb 15. Drug Res (Stuttg). 2023. PMID: 36791804 Clinical Trial.

3

Correction: Comparison of the efficacy of pioglitazone and metformin on ultrasound grade and liver enzymes level in patients with non-alcoholic fatty liver disease: A randomized controlled clinical trial.

Khoshbaten M, Beheshtirouy S, Shayanrad S, Gharekhani A, Rezaee H. Khoshbaten M, et al. Drug Res (Stuttg). 2023 Apr;73(4):e1. doi: 10.1055/a-2109-9465. Epub 2023 Jun 27. Drug Res (Stuttg). 2023. PMID: 37369353 No abstract available.

4

Chromium picolinate balances the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial.

Kooshki F, Moradi F, Karimi A, Niazkar HR, Khoshbaten M, Maleki V, Pourghassem Gargari B. Kooshki F, et al. Among authors: khoshbaten m. Eur J Gastroenterol Hepatol. 2021 Oct 1;33(10):1298-1306. doi: 10.1097/MEG.0000000000001830. Eur J Gastroenterol Hepatol. 2021. PMID: 32804855 Clinical Trial.

5

Efficacy of omega-3-rich Camelina sativa on the metabolic and clinical markers in nonalcoholic fatty liver disease: a randomized, controlled trial.

Musazadeh V, Dehghan P, Khoshbaten M. Musazadeh V, et al. Among authors: khoshbaten m. Eur J Gastroenterol Hepatol. 2022 May 1;34(5):537-545. doi: 10.1097/MEG.0000000000002297. Eur J Gastroenterol Hepatol. 2022. PMID: 35421019 Clinical Trial.

6

Aggressive hydration with Lactated Ringer's solution as the prophylactic intervention for postendoscopic retrograde cholangiopancreatography pancreatitis: A randomized controlled double-blind clinical trial.

Shaygan-Nejad A, Masjedizadeh AR, Ghavidel A, Ghojazadeh M, Khoshbaten M. Shaygan-Nejad A, et al. Among authors: khoshbaten m. J Res Med Sci. 2015 Sep;20(9):838-43. doi: 10.4103/1735-1995.170597. J Res Med Sci. 2015. PMID: 26759569 Free PMC article.

7

Effect of Aggressive Fluid Therapy on Outcomes after Endoscopic Retrograde Cholangiopancreatography: A Randomized Controlled Clinical Trial.

Ghaderi R, Ghojazadeh M, Khoshbaten M, Faravan A. Ghaderi R, et al. Among authors: khoshbaten m. Middle East J Dig Dis. 2019 Apr;11(2):76-83. doi: 10.15171/mejdd.2018.131. Epub 2019 Feb 10. Middle East J Dig Dis. 2019. PMID: 31380003 Free PMC article.

8

A pilot study of the effects of chromium picolinate supplementation on serum fetuin-A, metabolic and inflammatory factors in patients with nonalcoholic fatty liver disease: A double-blind, placebo-controlled trial.

Moradi F, Kooshki F, Nokhostin F, Khoshbaten M, Bazyar H, Pourghassem Gargari B. Moradi F, et al. Among authors: khoshbaten m. J Trace Elem Med Biol. 2021 Jan;63:126659. doi: 10.1016/j.jtemb.2020.126659. Epub 2020 Sep 30. J Trace Elem Med Biol. 2021. PMID: 33045675 Clinical Trial.

9

Co-supplementation of camelina oil and a prebiotic is more effective for in improving cardiometabolic risk factors and mental health in patients with NAFLD: a randomized clinical trial.

Kavyani M, Saleh-Ghadimi S, Dehghan P, Abbasalizad Farhangi M, Khoshbaten M. Kavyani M, et al. Among authors: khoshbaten m. Food Funct. 2021 Sep 20;12(18):8594-8604. doi: 10.1039/d1fo00448d. Food Funct. 2021. PMID: 34338703 Clinical Trial.

10

Does myo-inositol supplementation influence oxidative stress biomarkers in patients with non-alcoholic fatty liver disease?

Rostami S, Arefhosseini S, Tutunchi H, Khoshbaten M, Ebrahimi-Mameghani M. Rostami S, et al. Among authors: khoshbaten m. Food Sci Nutr. 2023 Dec 6;12(2):1279-1289. doi: 10.1002/fsn3.3842. eCollection 2024 Feb. Food Sci Nutr. 2023. PMID: 38370063 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

80 results

Search Page